



GSK prepares to bring bird-flu drug to IndiaPosted AtSify.comRelenza was not an anti-viral medicine
that GlaxoSmithKline (GSK) was planning to register
in India. But with bird-flu putting the global spotlight
on Relenza, along with Tamiflu, GSK has put in a `stock
requirement' for India with its parent company in London.Relenza
and Tamiflu (from Gilead-Roche) are the two drugs reported
to be effective against the bird-flu. Consequently,
governments across the world are in a race to stock
these drugs in the event of an outbreak. November 23, 2005
|